Brian Buntz

FDA's new AI assistant Elsa could speed drug reviews, but fragmented clinical trial data holds it back. Digital protocols and shared standards must come first.

The CDC recently overhauled its “Autism and Vaccines” webpage, telling readers that the familiar claim that “vaccines do not cause autism” is not evidence based.

The launch follows the viral popularity of Gemini 2.5 Flash Image, or “Nano Banana,” and signals that interest in more research oriented image generation is still ramping up.

New WIPO data shows a global patent boom driven by Asia and Big Tech, while Big Pharma adds far fewer new families and leans on older IP.

As 10x Genomics plugs Anthropic’s Claude into its cloud analysis stack, Michael Schnall-Levin, the company’s chief technology officer, is less interested in the novelty of “natural-language pipelines” than in solving a stubborn problem he calls the last mile of single-cell analysis. For years, 10x has invested heavily in software and visualization tools to automate early-stage…

As Anthropic rolls out Claude for Life Sciences, 10x Genomics is positioning its cloud as the analysis engine behind natural-language queries on giant single-cell datasets.

2025 has not exactly been a good year for life science labs. While the pandemic gave rise to something of a lab sugar rush, lab funding was already down at the start of 2025 and the downward trend has mostly accelerated since then. A wave of speculative deliveries met softer demand, pushing national vacancy higher…

Lab automation was supposed to commodify technicians. Replace manual pipetting with liquid handlers, and skilled laboratory workers would become interchangeable button-pushers. That theory hasn’t aged well. An analysis of federal wage data shows the role is not being devalued. It is splitting in two. From 2019 to 2024, the median wage for biological technicians rose…

Novo Nordisk's $5.2 billion acquisition of Akero Therapeutics sits at the center of 2025's hottest M&A space: MASH/metabolic disease.

Keytruda leads H1 2025 with $15.2B in sales, but faces 2028 patent expiry. Analysis of top pharmaceutical blockbusters, GLP-1 growth and market shifts.

BRANDTECH's Tom Friedlander, CPA with 30 years in automation, reveals ROI pitfalls like ignored idle time. Free Sept 30 webinar on LHS case study.

Did Artisan appoint an AI CEO? The startup's April Fools' marketing stunt features quotes from human and AI CEOs and potential R&D implications.

The Chinese EV giant BYD is shaking up the automotive market by breaking cost barriers in advanced driver-assistance systems (ADAS).

Meta splits Reality Labs into Wearables and Metaverse units amid financial losses and AI advances while continuing to hire AI experts.

Zai Lab builds global partnerships and advances therapies across therapeutic areas like oncology, autoimmune disorders, and neuroscience.

Moderna (Nasdaq:MRNA) CFO Jorge Gomez is gone from his new job effective immediately, the COVID-19 vaccine maker said today.

Pfizer announced that it has entered into an agreement to acquire Biohaven, which is best known for Nurtec ODT migraine therapy.

ProMed Pharma begins preclinical testing of resorbable contraceptive implant - Drug Delivery Business After receiving funding from the Bill & Melinda Gates Foundation, ProMed Pharma has begun preclinical evaluation of a novel fully resorbable contraceptive implant.